Ebola fears spark equipment companies to restrict service

Diagnostic labs refuse to accept patients' blood or tissue samples


Nervous about their products being used to test Ebola patients, medical device manufacturers are limiting support, service and warranties to hospitals, according to an article on the USA Today. Some labs are refusing to accept blood or tissue samples.

Some of these restrictions are irrational, hospital officials say.

According to The Centers for Disease Control and Prevention (CDC), devices used to test biological samples from Ebola patients can be disinfected and reused safely. Despite the CDC's reassurances, concerns about handling Ebola samples in lab environments continue.

Four large commercial diagnostic laboratories, which do specialized tests on blood and tissue, announced that they will not accept blood or tissue samples from Ebola patients, the article said.

"It's a pretty big hurdle for clinical labs to be prepared to provide lab testing to patients known or suspected to have Ebola," Daniel Diekema, president of the Society for Healthcare Epidemiology of America and head of the infectious disease division at the University of Iowa College of Medicine, said in the article. 

"One of the concerns, because of these messages from (equipment makers), is: Are we going to have to buy all new equipment and make a large capital investment."

Read the article.

 



November 19, 2014


Topic Area: Safety


Recent Posts

Harris Health to Build New Freestanding Cancer Center

The center is planned to open in 2029, following the opening of the new O'Quinn Hospital along the North Loop at Lockwood.


Inland Empire Health Plan Opens Expanded San Bernardino Community Wellness Center

The new 33,000-square-foot center is nearly three times the size of the original location off Second Street.


Rethinking Parking Lot Design at Irvine Heritage Medical Plaza

A new solar installation shows how healthcare facilities can improve parking amenities while boosting energy savings


Repurposing Healthcare Spaces: 5 Critical Questions

Done well, converting existing spaces can trim upfront project costs by up to 40 percent, compared with ground-up construction


Disinfectant Contact Time: The Case for Biofilm Disruption

Contact time, while essential for compliance, does not reliably predict microbial reduction on actual healthcare surfaces.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.